Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong
Pharmacoepidemiology and Drug Safety · 2023
DOI: 10.1002/pds.5638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2023. Verfasst von Wang Chun Kwok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Electronic Health Records, Clinical Coding. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background and Objective Electronic medical record (EMR) databases can facilitate epidemiology research in various diseases including bronchiectasis. Given the diagnostic challenges of bronchiectasis, the validity of the coding in EMR requires clarification. We aimed to assess the validity of International Classification of Diseases, 9th Revision (ICD‐9) code algorithms for identifying bronchiectasis in the territory‐wide electronic medical health record system of Clinical Data Analysis and Reporting System (CDARS) in Hong Kong. Materials and Methods Adult patients who had the diagnosis of bronchiectasis input from Queen Mary Hospital in 2011–2020 were identified using the ICD‐9 code of 494 by CDARS. All patients who had high resolution computed tomography (HRCT) were reviewed by respiratory specialists to confirm the presence of bronchiectasis on HRCT.
Results
A total of 19 617 patients who had the diagnostic code of bronchiectasis among all public hospitals in Hong Kong and 1866 in Queen Mary Hospital in the same period. Six hundred and forty‐eight cases were randomly selected and validated using medical record and HRCT review by a respiratory specialist. The overall positive predictive value (PPV) was 92.7% (95% CI 90.7–94.7).
Conclusions
This was the first ICD‐9 coding validation for bronchiectasis in Hong Kong CDARS. Our study demonstrated that using ICD‐9 code of 494 was reliable to support utility of CDARS database for further clinical research on bronchiectasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
- Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Wang Chun Kwok, Terence Chi Chun Tam, Chor Wing Sing, Esther Wai Yin Chan, Ching-Lung Cheung
Zitieren
APA
Kwok, W. C., Tam, T. C. C., Sing, C. W., Chan, E. W. Y., & Cheung, C. L. (2023). Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5638
Vancouver
Kwok WC, Tam TCC, Sing CW, Chan EWY, Cheung CL. Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong. Pharmacoepidemiology and Drug Safety. 2023. doi:10.1002/pds.5638
BibTeX
@article{Kwok2023,
author = {Kwok, Wang Chun and Tam, Terence Chi Chun and Sing, Chor Wing and Chan, Esther Wai Yin and Cheung, Ching-Lung},
title = {Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2023},
doi = {10.1002/pds.5638}
}
EUVIMED